Personal Mobility Devices Industry

The global personal mobility devices market size is expected to reach USD 17.97 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.8% from 2023 to 2030. The increasing R&D investments for the development of advanced mobility products and government initiatives to support reimbursement policies are some of the key factors boosting the market growth. The rising geriatric population and prevalence of chronic diseases, such as Parkinson’s, arthritis, and Alzheimer’s, are expected to drive the market over the forecast period.

The market is disrupted due to the COVID-19 pandemic during the second quarter of 2020 which affected the shipping and transportation of the devices. The decreasing production of these devices due to the pandemic has severely affected the industry's growth. The prices of wheelchairs and scooters have also been affected due to a decrease in the demand for the product. The market is likely to grow at a lucrative rate after the second half of 2020 as there is the ease of restrictions and an increase in the demand and requirement of the devices.

The rising number of surgical procedures, due to growing cases of cardiovascular and neurological cases and an increasing number of accidents and trauma cases, is contributing to the market growth. The regional market will retain its leading position throughout the forecast years. Developing healthcare infrastructure and growing healthcare expenditure are some of the factors contributing to its large share. Asia Pacific is expected to register the fastest CAGR during the forecast period due to the rising demand for personal mobility devices as a result of the growing geriatric population and increasing disposable income and awareness levels.

Gather more insights about the market drivers, restrains and growth of the Global Personal Mobility Devices market

Personal Mobility Devices Market Segments Highlights:

  • Wheelchairs was the largest product segment in 2022 owing to an increase in demand for powered wheelchairs, especially in developed countries, such as U.S., Canada, and U.K.
  • North America dominated the global market in 2022 due to increased healthcare expenditure and the geriatric population in the region
  • The Asia Pacific is expected to be the fastest-growing regional market during the forecast period owing to the rising geriatric population and increasing disposable income levels
  • Major market players are adopting various strategies to gain a competitive edge over others
  • Some of these strategies include strategic alliances with buyers and the development of advanced devices via extensive R&D investments

Personal Mobility Devices Market Report Segmentation

Grand View Research has segmented the global personal mobility devices market based on product and region:

Personal Mobility Devices Product Outlook (Volume, K Units; Revenue, USD Million, 2018 - 2030)

  • Walking Aids
    • Rollators
      • Premium Rollators
      • Low-Cost Rollators
    • Others (Canes, Crutches, and Walkers)
  • Wheelchairs
    • Manual wheelchairs
    • Powered Wheelchairs
  • Scooters

Personal Mobility Devices Regional Outlook (Volume, K Units; Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Key Personal Mobility Devices Company Insights

  • Drive DeVilbiss Healthcare
  • GF Health Products, Inc.
  • Invacare Corporation
  • Carex Health Brands, Inc.
  • Kaye Products, Inc.
  • Briggs Healthcare
  • Medline Industries, Inc.
  • NOVA Medical Products
  • Performance Health
  • Rollz International

Order a free sample PDF of the Personal Mobility Devices Market Intelligence Study, published by Grand View Research.